SIGA Technologies, Inc. is a pharmaceutical company set up in 1995 that is now based in New York City.

Pharmaceutical

SIGA Technologies

SIGA Technologies' headquarters in New York, NY, United States

Phillip Louis Gomez III 

Suzanne Harnett

Kristin Murray

Steve Vicik

Larry Miller

Edmund O.

Tove Bolken

Annie O.

Dennis E. Hruby

Daniel J. Luckshire

Joseph W. Chip Marshall, III

Gary J. Nabel

Harold Ford, Jr.

Jaymie A. Durnan

Julian Nemirovsky

Holly Phillips

Evan Knisely

Jay K. Varma

This department provides strategic direction and oversight for the organization.

Executive Leadership

The Finance and Accounting Team at SIGA Technologies is responsible for managing the company's financial health, including budgeting, forecasting, and financial reporting. They ensure compliance with accounting regulations and oversee cost accounting to optimize resource allocation. This team also plays a crucial role in financial strategy and stewardship, supporting the company’s mission to develop pharmaceutical solutions.

Finance and Accounting Team

This department focuses on the application and development of analytical methods and techniques to support scientific research and data analysis.

Analytical Science

This department manages employee relations, recruitment, training, and organizational development.

Human Resources

The Regulatory and Quality Assurance team at SIGA Technologies ensures that all pharmaceutical products comply with industry regulations and quality standards. This team is responsible for preparing and submitting regulatory documentation, conducting quality audits, and maintaining communication with regulatory agencies to facilitate product approvals and ensure ongoing compliance throughout the product lifecycle.

Regulatory and Quality Assurance

The Research and Development team at SIGA Technologies focuses on innovative pharmaceutical solutions, particularly targeting poxvirus infections and other infectious diseases. This multidisciplinary team, comprising senior scientists and clinical development experts, conducts rigorous research, oversees animal studies, and leads clinical trials to advance the company's therapeutic candidates from conception through development. Their efforts are pivotal in enhancing the effectiveness and safety of next-generation antiviral therapies.

SIGA Technologies

Org chart

Board & advisors

Teams

Executive Leadership

Finance and Accounting Team

Analytical Science

Human Resources

Regulatory and Quality Assurance

Research and Development

Offices

SIGA Technologies

Org chart

Board & advisors

Teams

Executive Leadership

Finance and Accounting Team

Analytical Science

Human Resources

Regulatory and Quality Assurance

Research and Development

Offices

Related companies